Objective. Inhibitors of prostaglandin production, such as nonsteroidal antiinflammatory drugs (NSAIDs), and pharmacologic nitric oxide (NO) donors, such as organic nitrates, have been suggested to protect against bone loss in both humans and experimental animals. Recently, a new class of nitrosylat
Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL
✍ Scribed by Lorenz C. Hofbauer; Ute Zeitz; Michael Schoppet; Monika Skalicky; Christiane Schüler; Marina Stolina; Paul J. Kostenuik; Reinhold G. Erben
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 324 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Lipopolysaccharide (LPS) is a known inducer of numerous pro-inflammatory events including the production of platelet-activating factor (PAF). PAF released in response to LPS is a major contributor to the pathological events associated with endotoxemia. The present study demonstrates that dexmethason
People are widely exposed during their lifetime to many biological, chemical, and physical agents in the environment and at work. In this paper the effects of combined exposures of nonmutagenic doses of X-rays and anticancer agents (cyclophosphamide, mitomycin C, and vinblastine) have been investiga